NMPA Approval

Lamivudine and Tenofovir disoproxil fumarate Tablets

Approval Number

国药准字H20249842

Company上海迪赛诺医药集团股份有限公司

Registration Date

December 25, 2024

Drug Information

Generic Name

拉米夫定替诺福韦片

Dosage Form

片剂

Strength

每片含拉米夫定300mg和富马酸替诺福韦二吡呋酯300mg

Drug Type

化学药品

Registration Date

December 25, 2024

Company Information

Applicant Company

Company Name上海迪赛诺医药集团股份有限公司

Company Address

中国（上海）自由贸易试验区张衡路1479号1幢

Manufacturing Company

Company Name江苏诚康药业有限公司

Company Address

江苏大丰盐土大地海洋生物产业科技园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.